Salus Scientific Participates in TCT 2026 to Highlight Comprehensive Radiation Protection Solutions

CHARLESTON, S.C., Oct. 23, 2026 /CourierPR/ -- Salus Scientific, a medical technology company, will participate in the Transcatheter Cardiovascular Therapeutics (TCT) 2026 conference from October 31 to November 3 in San Diego. The company will showcase its comprehensive, integrated portfolio of technologies and programs designed to protect physicians, nurses, technologists, and other healthcare professionals working in fluoroscopy-guided procedures.

The company's participation follows the recent publication of the multi-society ALARA+ Consensus Statement, which has intensified the discussion around occupational radiation safety and enhanced radiation protection technologies in procedural medicine. The recommendations underscore the need to address occupational risks facing healthcare professionals who work in fluoroscopy-guided environments throughout their careers.

For these professionals, the challenge extends beyond radiation exposure. Traditional lead protection can also contribute to musculoskeletal strain and orthopedic injury, creating a need for more comprehensive approaches to protecting the procedural team. Salus Scientific was founded on the belief that occupational hazards should not be accepted as an unavoidable part of a career in medicine. The company's portfolio includes the AeroShield™ Enhanced Radiation Protection System, designed to reduce scatter radiation exposure across the procedural team, and the GLiFT™ Endoskeleton System, which transfers the weight of protective garments away from the shoulders and spine to the hips and pelvis.

More than 24 million fluoroscopy-guided procedures are performed annually, exposing healthcare professionals to cumulative scatter radiation while traditional lead protection contributes to significant orthopedic injury and chronic pain over the course of a career. A recent industry survey found that nearly 60 percent of interventionalists report orthopedic injuries associated with wearing lead protection.

Salus Scientific's booth at TCT 2026 will engage with physicians, healthcare leaders, and other stakeholders on the evolving approaches to radiation protection and workforce safety.

At TCT 2026, Salus Scientific will highlight its AeroShield™ Enhanced Radiation Protection System, GLiFT™ Endoskeleton System, real-time dosimetry and radiation monitoring solutions, and radiation protection education, compliance, and support programs. The company also entered into a strategic distribution agreement with USVetServ this summer to expand access to its technologies across Veterans Affairs and Department of Defense healthcare facilities.

The ALARA+ recommendations reflect what many have known for years: we can and must do better. Salus Scientific's comprehensive approach addresses both radiation exposure and the physical demands of traditional lead protection while preserving clinical workflow and patient care.